Two new broker notes out last week on this one -

Collins Stewart gives a target valuation for the combined entity of 26 million or 156p per share

Edison Investments embedded valuation is 31m - Indicating a 100% gain in share price from current levels. They suggest that using the current embedded valuation model, the current value of Angles six non-exited ventures is only 5.5m - suggesting Angle to be SIGNIFICANTLY UNDERVALUED

Have a look

Blue today.....good progress here...

Appointment of Scientific Adviser

Looking good.....200p plus is my target....42 million market cap.....imagine if hospitals all over the world adopt their cancer cell trap system....

Intellectual Property Update

Yep...progressing nicely.....

RF - do you still follow these - the up trend is well and truly broken.

Yes...not too happy....expected a better performance from the sp...will stay put...perhaps some good news is on the way...

They are on my wish list - it looks like things may become clearer later this year.

Parsortix Evaluation

Upward trend here....nice....

Learn from the experts



You can now book your free tickets for our big event on Saturday 13 September in partnership with the London Stock Exchange. Held at the Business Design Centre in Islington, North London, The Stock Market Show is a full day event designed to help you understand investing. We have secured a large number of financial experts to explain in simple terms how you should go about investing in the stock market, the ways in which to research individual stocks and how to use different investment and trading accounts.



Tickets for the event are free but must be booked in advance you can also book your seminar sessions on our five separate stages.

The day is about to become a hot talking point among investors across the country as we are very pleased to announce This is Money as our media partner, a website read by millions of people and part of the Daily Mail & General Trust (DMGT) media stable.

• Hear from more than 50 speakers across 5 stages including: product experts, CEOs from listed companies and renowned journalists from Shares including Daniel Coatsworth, Mark Dunne, Steven Frazer and Tom Sieber who will all be giving presentations on investing.

• Speak with over 40 exhibitors from a range of AIM companies brokers and platform providers including: Alecto Minerals, Advanced Computer Software Group, Angle, Avation, Azonto Petroleum, Chaarat Gold, Corero Group Services, eg Solutions, EMIS, Fastnet Oil & Gas, Flowgroup, Fox Marble, Getech, Horizon Discovery, InternetQ, NetDimensions, Nostra Terra Oil & Gas, Premier African Minerals, Valirx, Velocys, Wishbone Gold and XL Media.

• Learn about investment topics tailored to suit a range of investors from novice to expert

• Meet with top financial services providers including; Aberdeen Asset Management, AJ Bell Youinvest, Amati Global Investors, Boost, CMC Markets, ETF Securities, Hargreaves Lansdown, IG, Killik & Co, KPMG, London Stock Exchange, Panmure Gordon, Reyker Securities,Société Générale, Stockopedia and ThisisMoney.


Why you should attend:

We have structured the entire programme around one core principal: financial education



Learn about:

• What you need to become a successful investor

• Managing your own pension using stocks and shares

• The simple approach to valuing companies

• The importance of risk when researching stocks

• The most important areas in company documents and financial accounts

• Reading chart patterns

• An introduction to exchange traded funds and bonds

• Plus a host of other topics on industry sectors, trading techniques, market mechanics and tax issues



Hear from:

• Shares journalists

• Financial services professionals

• Chief executives of quoted companies

• Leading market commentators



Your chance to meet:

• Share dealing and pension providers

• Quoted companies

• Shares journalists

• Representatives from the London Stock Exchange

• Fellow investors

For more information and to register go to: http://www.thestockmarketshow.com/

Could rocket if this becomes some sort of universal standard for cancer cell capture worldwide !.......profits could be staggering !....

"Unprecedented Specificity" in Ovarian Cancer

Well...at least this one looks promising....

Well I don't know about that skinny, but I do know I need a stiff drink after selling too soon! :o)

Not sure about viagra....but as my sharepicking has been hopeless lately.....anyway ; this looks to have fantastic potential !....now I've said that : watch it dive...

Could be a longish haul but for a long term punt it has loads of potential. I was waiting for the sp to pull back a bit before buying back in. I must rename myself as stupidboypike!

200p plus could be on the cards here.

I've been watching for ages, but don't hold either!

Interims tomorrow!